|
Name |
Cinerolon
|
| Molecular Formula | C10H14O2 | |
| IUPAC Name* |
2-[(Z)-but-2-enyl]-4-hydroxy-3-methylcyclopent-2-en-1-one
|
|
| SMILES |
C/C=C\CC1=C(C(CC1=O)O)C
|
|
| InChI |
InChI=1S/C10H14O2/c1-3-4-5-8-7(2)9(11)6-10(8)12/h3-4,9,11H,5-6H2,1-2H3/b4-3-
|
|
| InChIKey |
YLKLJBPHNWWPSF-ARJAWSKDSA-N
|
|
| Synonyms |
Cinerolon; Cinerolone; 17190-74-8; 2-[(Z)-but-2-enyl]-4-hydroxy-3-methylcyclopent-2-en-1-one; 2-Cyclopenten-1-one, 2-(2-butenyl)-4-hydroxy-3-methyl-, (Z)-; Z-Cinerolone; 2-[(Z)-BUT-2-ENYL]-4-HYDROXY-3-METHYL-CYCLOPENT-2-EN-1-ONE; cis -Cinerolone; SCHEMBL10631200; 2-[(2Z)-2-Butenyl]-4-hydroxy-3-methyl-2-cyclopenten-1-one; 2-Cyclopenten-1-one, 2-(2Z)-2-buten-1-yl-4-hydroxy-3-methyl-
|
|
| CAS | 17190-74-8 | |
| PubChem CID | 5374041 | |
| ChEMBL ID | NA |
Chemical Classification: |
|
|
|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
|---|---|---|---|---|---|---|---|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
| Molecular Weight: | 166.22 | ALogp: | 0.7 |
| HBD: | 1 | HBA: | 2 |
| Rotatable Bonds: | 2 | Lipinski's rule of five: | Accepted |
| Polar Surface Area: | 37.3 | Aromatic Rings: | 1 |
| Heavy Atoms: | 12 | QED Weighted: | 0.638 |
| Caco-2 Permeability: | -4.351 | MDCK Permeability: | 0.00002480 |
| Pgp-inhibitor: | 0.001 | Pgp-substrate: | 0.003 |
| Human Intestinal Absorption (HIA): | 0.007 | 20% Bioavailability (F20%): | 0.005 |
| 30% Bioavailability (F30%): | 0.004 |
| Blood-Brain-Barrier Penetration (BBB): | 0.906 | Plasma Protein Binding (PPB): | 32.99% |
| Volume Distribution (VD): | 0.82 | Fu: | 65.86% |
| CYP1A2-inhibitor: | 0.031 | CYP1A2-substrate: | 0.412 |
| CYP2C19-inhibitor: | 0.032 | CYP2C19-substrate: | 0.739 |
| CYP2C9-inhibitor: | 0.011 | CYP2C9-substrate: | 0.652 |
| CYP2D6-inhibitor: | 0.006 | CYP2D6-substrate: | 0.337 |
| CYP3A4-inhibitor: | 0.038 | CYP3A4-substrate: | 0.274 |
| Clearance (CL): | 15.601 | Half-life (T1/2): | 0.901 |
| hERG Blockers: | 0.008 | Human Hepatotoxicity (H-HT): | 0.114 |
| Drug-inuced Liver Injury (DILI): | 0.567 | AMES Toxicity: | 0.041 |
| Rat Oral Acute Toxicity: | 0.206 | Maximum Recommended Daily Dose: | 0.036 |
| Skin Sensitization: | 0.69 | Carcinogencity: | 0.597 |
| Eye Corrosion: | 0.949 | Eye Irritation: | 0.969 |
| Respiratory Toxicity: | 0.727 |
| Similar NPs | Similar Drugs | ||||||
|---|---|---|---|---|---|---|---|
| NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
| ENC001459 | ![]() |
0.354 | D0H6VY | ![]() |
0.193 | ||
| ENC003622 | ![]() |
0.341 | D06XWB | ![]() |
0.188 | ||
| ENC005957 | ![]() |
0.321 | D0N0OU | ![]() |
0.184 | ||
| ENC005292 | ![]() |
0.316 | D0CL9S | ![]() |
0.182 | ||
| ENC001840 | ![]() |
0.300 | D0T3NY | ![]() |
0.177 | ||
| ENC005984 | ![]() |
0.288 | D0Z4BV | ![]() |
0.173 | ||
| ENC002343 | ![]() |
0.273 | D0R2KF | ![]() |
0.169 | ||
| ENC002751 | ![]() |
0.269 | D0X7JN | ![]() |
0.167 | ||
| ENC004982 | ![]() |
0.267 | D0S5CH | ![]() |
0.167 | ||
| ENC004404 | ![]() |
0.267 | D04VIS | ![]() |
0.163 | ||